예측 기간
시장 규모(기준 연도)
시장 규모(예측 연도)
연평균 성장률유럽 미세 침습성 녹내장 수술(MIGS) 장치 시장, 제품 유형별(MIGS 션트, MIGS 스텐트, 트라벡톰, 카후크 듀얼 블레이드, 튜브 션트, 미세 임플란트, 미세 카테터 및 기타), 대상(트라베큘라 망사, 맥락막상 공간, 결막하 여과, 방수 생성 감소 및 기타), 수술 유형(백내장과 관련된 녹내장, 단독 녹내장), 녹내장 유형(개방각 녹내장, 급성 폐쇄각 녹내장, 정상 긴장 녹내장, 이차 녹내장, 색소성 녹내장 및 선천성 녹내장), 최종 사용자(병원 외래 환자 부서(HOPD), 안과 진료소, 외래 수술 센터 (ASCS) 및 기타), 유통 채널(직접 입찰, 소매 판매 및 기타) - 업계 동향 및 2030년까지의 예측.
유럽 미세 침습성 녹내장 수술(MIGS) 장치 시장 분석 및 통찰력
미세 침습성 녹내장 수술(MIGS)은 개방각 녹내장을 치료하는 데 사용됩니다. 처음에는 OAG를 치료하기 위해 방수 생성을 줄이거나 방수 유출을 늘리는 약물을 투여했습니다. 경증에서 중등도의 OAG의 경우 전통적으로 약물 치료와 레이저 치료를 시행했습니다. 미세 침습성 녹내장 수술(MIGS) 시술이 등장하면서 기존 수술에 적합하지 않은 사람들을 위한 새로운 옵션이 만들어졌습니다. 노인 인구가 증가하고 실명을 예방하기 위한 정부 이니셔티브가 증가함에 따라 시장이 활성화될 것으로 예상됩니다. 녹내장 약물에서 최소 침습성 녹내장 수술로의 빠른 전환은 MIGS 장치 제조업체에 기회를 창출할 수 있습니다.
Data Bridge Market Research는 유럽 미세 침습성 녹내장 수술(MIGS) 장치 시장이 2030년까지 1,738.15백만 달러 규모에 도달할 것으로 예상하고 있으며, 2023-2030년 예측 기간 동안 연평균 성장률은 29.7%에 이를 것으로 분석했습니다. MIGS 션트는 최소 침습 수술 장치에 대한 수요가 증가함에 따라 시장에서 가장 큰 제품 유형 세그먼트를 차지합니다.
|
보고서 메트릭 |
세부 |
|
예측 기간 |
2023년부터 2030년까지 |
|
기준 연도 |
2022 |
|
역사적 연도 |
2021 (2015-2020으로 사용자 정의 가능) |
|
양적 단위 |
매출은 백만 달러, 볼륨은 단위, 가격은 달러로 표시됨 |
|
다루는 세그먼트 |
제품 유형(MIGS 션트, MIGS 스텐트, 트라벡톰, 카후크 듀얼 블레이드, 튜브 션트, 마이크로 임플란트, 마이크로 카테터 및 기타), 대상(트라베큘라 메쉬워크, 초맥락막 공간, 결막하 여과, 방수 생성 감소 및 기타), 수술 유형(백내장과 관련된 녹내장, 단독 녹내장), 녹내장 유형(개방각 녹내장, 급성 폐쇄각 녹내장, 정상 긴장 녹내장, 이차 녹내장, 색소성 녹내장 및 선천성 녹내장), 최종 사용자(병원 외래 환자 부서(HOPD), 안과 진료소, 외래 수술 센터(ASCS) 및 기타), 유통 채널(직접 입찰, 소매 판매 및 기타) |
|
적용 국가 |
Germany, U.K., France, Italy, Russia, Spain, Turkey, Switzerland, Netherlands, Belgium, Denmark, Poland, Sweden, Norway, Finland and Rest of Europe |
|
Market Players Covered |
Glaukos corporation, AbbVie Inc., Alcon, Johnson & Johnson Vision Care Inc., Sight sciences, Inc., Santen Pharmaceutical Co., Ltd, iSTAR Medical, BVI, Nova Eye Medical, Lumenis Be Ltd, Inami & Co., Ltd, Oertli Instrumente AG, Lumibird |
Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Market Definition
MIGS stands for micro invasive glaucoma surgery, which helps treat glaucoma. It is a breakthrough technology in the treatment of mild to moderate glaucoma. It is an alternative to the medications given earlier, and it also prevents the complications of conventional surgery. These procedures are used to lower the intra-ocular pressure of the eye to avoid damage to the optic nerve. These procedures are safer and have a very rapid recovery time compared to conventional surgery. The various MIGS devices implanted are shunts and stents to lower the IOP.
The growing incidences of eye diseases, rising demand for micro invasive glaucoma surgery, rising number of players in the market, and novel product launches are also propelling the growth of the Europe micro invasive surgery device market (MIGS).
Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
- Growth in Popularity of Minimally Invasive Surgery
Glaucoma is the second most common cause of blindness. According to WHO, 4.5 million people are blind because of glaucoma. The only effective treatment of glaucoma is to lower intra-ocular pressure so that there is no damage to the optic nerve. Earlier, there were only three ways to treat glaucoma; medications, laser therapy, and in severe cases, incisional surgeries. The medicines have some drawbacks, like patient adherence and ocular toxicity. Also, these are costly and are only available to some in developing countries. Laser therapies, though, are non-invasive. They lose their effectiveness over the period. Incisional surgeries are the most effective treatment to lower intraocular pressure. Still, they can fail due to scarring, decreased quality of life due to bleb-related foreign body sensation, induced astigmatism, and secondary cataracts.
MIGS provide provides safer, less invasive means of reducing intraocular pressure. Also, they reduce the dependencies on medication. They have quicker recovery time and modest results compared to incisional surgeries. Hence, surgeons and patients are increasingly adopting these micro-invasive surgeries. Therefore, the growing popularity of minimally invasive surgery is expected to drive the market growth.
- Rise in Incidence of Glaucoma
The cause of irreversible global blindness is majorly glaucoma. A glaucoma is a group of eye disorders that have very little to no symptoms in the initial stage but afterward lead to damage of optic nerves, which can lead to vision loss or blindness. The prevalence of glaucoma has been increasing.
Improving the quality of life is instrumental to reducing the burden of glaucoma, as it has several severe risk factors. It is necessary to shift to revolutionary techniques like micro invasive glaucoma surgery to overcome it at an early stage. Therefore this creates a demand for MIGS devices; hence an increasing incidence of glaucoma is expected to act as a driver for the market.
Opportunity
-
Introduction of Technological Advanced Product
Glaucoma is a severe eye disease that can lead to vision loss if not controlled. It generally does not lead to blindness as it can be controlled by modern treatment and many options for preventing further damage. With the increased scientific developments, there has been a revolutionary change in the treatment of glaucoma. With the advent of micro-invasive glaucoma surgery, there is a paradigm shift in medicine as it can help in the treatment of glaucoma at an early stage and avoid the dependency on filtration surgeries like trabeculectomy. This also overcomes the risks associated with these incisional surgeries. There are various advancements in the treatment of glaucoma with MIGS.
These new technologies are safer, and they give modest to good results. Therefore these are being increasingly adopted by patients and surgeons. This creates an opportunity for manufacturers to produce more technologically advanced devices. Hence, introducing technologically advanced products might act as an opportunity for the market.
Restraints/ Challenges
-
Inadequate Reimbursement Scenario
Vision is on the line with glaucoma; many people continue to lose sight daily with this disease. Patients with mild to moderate glaucoma received medical therapy conventionally, and the surgical options were confined to people with severe glaucoma. However, there is a paradigm shift in the treatment of glaucoma with the introduction of MIGS devices. Advanced glaucoma damage can be avoided by performing micro invasive glaucoma surgery at an early stage.
The surgeons don’t prefer to use MIGS devices because the reimbursements are so low. When the people are not paid for it, they stop using it, and ultimately its production stops. Although MIGS devices are revolutionizing the treatment of glaucoma, the approval and payment by insurance companies of these devices are seen as an obstacle. Therefore, poor reimbursements are expected to be considered a restraint for the market.
- Lack of Skilled Professionals with Adequate Knowledge
Intra-ocular surgery is a very complex task as the work has to be done in smaller spaces adjacent to susceptible structures where any mistake can lead to permanent vision loss. This makes the presence of skilled professionals a necessity for the surgery. Performing MIGS requires an even higher skill level because it involves the treatment, working in smaller, more sensitive spaces within the eye, and learning a new proprioceptive skill, namely intraoperative surgical gonioscopic viewing of the angle. Though the presence of skilled professionals is highly required, there is an acute shortage of trained surgeons in developing countries.
Even more, scarcity can be observed in professionals specialized in ophthalmological surgery across the globe, making it a severe problem in treating glaucoma. As the numbers of surgeons are meager, the number of surgical procedures will be deficient; therefore, this is seen as an obstacle. Thus, a high level of market dependency on the availability of skilled professionals with adequate knowledge might challenge the market.
Recent Development
- In February 2022, Santen is launching an innovative, interactive medical education platform for healthcare professionals (HCPs). It gives ophthalmologists access to high-quality, personalized learning at their own pace. This will help increase awareness amongst healthcare professionals and lead to better treatment and growth for the company
Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Market Scope
The Europe micro invasive glaucoma surgery (MIGS) devices market is categorized into six segments by product type, target, surgery type, glaucoma type, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
Product Type
- Migs Stents
- Migs Shunts
- Trabectome
- Kahook Dual Blade
- Tube Shunt
- Micro Implants
- Micro Catheters
- Others
On the basis of product type, the Europe micro invasive glaucoma surgery (MIGS) devices market is segmented into MIGS shunts, MIGS stents, trabectome, kahook dual blade, tube shunt, micro implants, micro catheters and others.
Target
- Trabecular Meshwork
- Suprachoroidal Space
- Subconjunctival Filtration
- Reducing aqueous Production
- Others
On the basis of target, the europe micro invasive glaucoma surgery (migs) devices market is segmented into the trabecular meshwork, suprachoroidal space, subconjunctival filtration, reducing aqueous production and others.
Surgery Type
- Glaucoma in Conjunction with Cataract
- Stand-alone Glaucoma
On the basis of surgery type, the europe micro invasive glaucoma surgery (MIGS) devices market is segmented into glaucoma in conjunction with cataract and stand-alone glaucoma.
Glaucoma Type
- Open- angle Glaucoma
- Acute angle- closure Glaucoma
- Normal – tension Glaucoma
- Secondary Glaucoma
- Pigmentary Glaucoma
- Congenital Glaucoma
녹내장 유형을 기준으로 유럽 미세 침습성 녹내장 수술(MIGS) 장치 시장은 개방각 녹내장, 급성 폐쇄각 녹내장, 정상 안압 녹내장, 2차 녹내장, 색소성 녹내장 및 선천성 녹내장으로 구분됩니다.
최종 사용자
- 병원 외래 진료과 (HOPD)
- 안과 진료소
- 외래 수술 센터(ASCS)
- 기타
유럽 미세 침습적 녹내장 수술(MIGS) 장치 시장은 최종 사용자 기준으로 병원 외래 환자 부서(HOPD), 안과 진료소, 외래 수술 센터(ASCS) 및 기타로 구분됩니다.
유통 채널
- 직접 입찰
- 소매 판매
- 기타
유럽 미세 침습성 녹내장 수술(MIGS) 장치 시장은 유통 채널을 기준으로 직접 입찰과 소매 판매로 구분됩니다.
유럽 미세 침습성 녹내장 수술(MIGS) 장치 시장 지역 분석/통찰력
유럽 미세 침습성 녹내장 수술(MIGS) 장치 시장은 제품 유형, 대상, 수술 유형, 녹내장 유형, 최종 사용자 및 유통 채널에 따라 6개 세그먼트로 분류됩니다.
이 시장 보고서에 포함된 국가로는 독일, 영국, 프랑스, 이탈리아, 러시아, 스페인, 터키, 스위스, 네덜란드, 벨기에, 덴마크, 폴란드, 스웨덴, 노르웨이, 핀란드, 그리고 나머지 유럽 국가가 있습니다.
독일은 인구 중 녹내장이나 이와 관련된 문제의 유병률이 증가하면서 우위를 점하고 있습니다.
보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 신규 판매, 교체 판매, 국가 인구 통계, 규제 조치 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 지역 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 판매 채널의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.
경쟁 환경 및 유럽 미세 침습성 녹내장 수술(MIGS) 장치 시장 점유율 분석
유럽 미세 침습성 녹내장 수술(MIGS) 장치 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, R&D 투자, 새로운 시장 이니셔티브, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 제품 승인, 제품 폭 및 호흡, 응용 프로그램 우세, 기술 수명선 곡선이 있습니다. 위에 제공된 데이터 포인트는 유럽 미세 침습성 녹내장 수술(MIGS) 장치 시장에 대한 회사의 초점과만 관련이 있습니다.
유럽 미세 침습성 녹내장 수술(MIGS) 장치 시장의 주요 기업으로는 Glaukos Corporation, AbbVie Inc., Alcon, Johnson & Johnson Vision Care Inc., Sight sciences, Inc., Santen Pharmaceutical Co., Ltd, iSTAR Medical, BVI, Nova Eye Medical, Lumenis Be Ltd, Inami & Co., Ltd, Oertli Instrumente AG, Lumibird 등이 있습니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCTS LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PRIMIUM INSIGHT
4.1 PESTEL
4.2 PORTER
5 VALUE CHAIN ANALYSIS
6 INDUSTRY INSIGHTS
6.1 MICRO AND MACROECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
7 COST ANALYSIS BREAKDOWN
8 TECHNOLOGY ROADMAP
9 REIMBURSEMENT FRAMEWORK
10 INNOVATION TRACKER AND STRATEGIC ANALYSIS
11 REGULATION
12 MARKET OVERVIEW
12.1 DRIVERS
12.1.1 INCREASE IN THE GERIATRIC POPULATION
12.1.2 RISE IN INCIDENCE OF GLAUCOMA
12.1.3 GROWTH IN THE POPULARITY OF MINIMALLY INVASIVE SURGERY
12.2 RESTRAINTS
12.2.1 INADEQUATE REIMBURSEMENT SCENARIO
12.2.2 STRINGENT REGULATIONS FOR MIGS DEVICES
12.3 OPPORTUNITIES
12.3.1 RAPID TRANSITION FROM GLAUCOMA MEDICATION TO MINIMALLY INVASIVE GLAUCOMA SURGERIES
12.3.2 INTRODUCTION OF TECHNOLOGICAL ADVANCED PRODUCT
12.4 CHALLENGES
12.4.1 LACK OF SKILLED PROFESSIONALS WITH ADEQUATE KNOWLEDGE
12.4.2 RISKS ASSOCIATED WITH MICRO INVASIVE GLAUCOMA SURGERY
13 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE
13.1 OVERVIEW
13.2 MIGS STENTS
13.3 MIGS SHUNTS
13.4 TRABECTOME
13.5 KAHOOK DUAL BLADE
13.6 TUBE SHUNT
13.7 MICRO IMPLANTS
13.8 MICRO CATHETERS
13.9 OTHERS
14 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET
14.1 OVERVIEW
14.2 TRABECULAR MESHWORK
14.3 REDUCING AQUEOUS PRODUCTION
14.4 SUPRACHOROIDAL SPACE
14.5 SUBCONJUNCTIVAL FILTRATION
14.6 OTHERS
15 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE
15.1 OVERVIEW
15.2 GLAUCOMA IN CONJUNCTION WITH CATARACT
15.3 STAND-ALONE GLAUCOMA
16 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE
16.1 OVERVIEW
16.2 OPEN ANGLE GLAUCOMA
16.3 ACUTE ANGLE GLAUCOMA
16.4 NORMAL TENSION GLAUCOMA
16.5 SECONDARY GLAUCOMA
16.6 PIGMENTARY GLAUCOMA
16.7 CONGENITAL GLAUCOMA
17 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER
17.1 OVERVIEW
17.2 HOSPITAL OUTPATIENT DEPARTMENT (HOPD)
17.3 OPHTHALMOLOGY CLINICS
17.4 AMBULATORY SURGERY CENTERS (ASCS)
17.5 OTHERS
18 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL
18.1 OVERVIEW
18.2 DIRECT TENDER
18.3 RETAIL SALES
18.4 OTHERS
19 EUROPE
19.1 GERMANY
19.2 U.K.
19.3 FRANCE
19.4 ITALY
19.5 RUSSIA
19.6 SPAIN
19.7 TURKEY
19.8 SWITZERLAND
19.9 NETHERLANDS
19.1 BELGIUM
19.11 DENMARK
19.12 POLAND
19.13 SWEDEN
19.14 NORWAY
19.15 FINLAND
19.16 REST OF EUROPE
20 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY LANDSCAPE
20.1 COMPANY SHARE ANALYSIS: EUROPE
21 SWOT ANALYSIS
22 QUESTIONNAIRE
23 RELATED REPORTS
표 목록
TABLE 1 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 2 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 3 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 4 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 5 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 6 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 7 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 8 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 9 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 10 EUROPE MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 11 EUROPE MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 12 EUROPE MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 13 EUROPE I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 14 EUROPE I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 15 EUROPE I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 16 EUROPE TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 17 EUROPE TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 18 EUROPE TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 19 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 20 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 21 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 22 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 23 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 24 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 25 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 26 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 27 GERMANY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 28 GERMANY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 29 GERMANY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 30 GERMANY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 31 GERMANY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 32 GERMANY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 33 GERMANY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 34 GERMANY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 35 GERMANY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 36 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 37 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 38 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 39 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 40 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 41 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 42 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 43 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 44 U.K. MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 45 U.K. MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 46 U.K. MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 47 U.K. I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 48 U.K. I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 49 U.K. I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 50 U.K. TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 51 U.K. TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 52 U.K. TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 53 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 54 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 55 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 56 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 57 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 58 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 59 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 60 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 61 FRANCE MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 62 FRANCE MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 63 FRANCE MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 64 FRANCE I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 65 FRANCE I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 66 FRANCE I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 67 FRANCE TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 68 FRANCE TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 69 FRANCE TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 70 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 71 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 72 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 73 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 74 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 75 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 76 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 77 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 78 ITALY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 79 ITALY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 80 ITALY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 81 ITALY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 82 ITALY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 83 ITALY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 84 ITALY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 85 ITALY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 86 ITALY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 87 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 88 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 89 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 90 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 91 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 92 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 93 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 94 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 95 RUSSIA MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 96 RUSSIA MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 97 RUSSIA MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 98 RUSSIA I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 99 RUSSIA I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 100 RUSSIA I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 101 RUSSIA TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 102 RUSSIA TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 103 RUSSIA TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 104 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 105 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 106 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 107 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 108 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 109 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 110 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 111 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 112 SPAIN MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 113 SPAIN MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 114 SPAIN MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 115 SPAIN I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 116 SPAIN I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 117 SPAIN I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 118 SPAIN TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 119 SPAIN TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 120 SPAIN TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 121 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 122 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 123 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 124 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 125 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 126 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 127 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 128 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 129 TURKEY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 130 TURKEY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 131 TURKEY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 132 TURKEY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 133 TURKEY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 134 TURKEY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 135 TURKEY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 136 TURKEY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 137 TURKEY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 138 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 139 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 140 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 141 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 142 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 143 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 144 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 145 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 146 SWITZERLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 147 SWITZERLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 148 SWITZERLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 149 SWITZERLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 150 SWITZERLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 151 SWITZERLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 152 SWITZERLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 153 SWITZERLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 154 SWITZERLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 155 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 156 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 157 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 158 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 159 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 160 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 161 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 162 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 163 NETHERLANDS MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 164 NETHERLANDS MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 165 NETHERLANDS MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 166 NETHERLANDS I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 167 NETHERLANDS I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 168 NETHERLANDS I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 169 NETHERLANDS TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 170 NETHERLANDS TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 171 NETHERLANDS TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 172 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 173 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 174 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 175 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 176 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 177 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 178 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 179 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 180 BELGIUM MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 181 BELGIUM MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 182 BELGIUM MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 183 BELGIUM I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 184 BELGIUM I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 185 BELGIUM I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 186 BELGIUM TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 187 BELGIUM TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 188 BELGIUM TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 189 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 190 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 191 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 192 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 193 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 194 DENMARK MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 195 DENMARK MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 196 DENMARK MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 197 DENMARK MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 198 DENMARK MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 199 DENMARK MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 200 DENMARK I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 201 DENMARK I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 202 DENMARK I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 203 DENMARK TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 204 DENMARK TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 205 DENMARK TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 206 DENMARK MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 207 DENMARK MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 208 DENMARK MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 209 DENMARK MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 210 DENMARK MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 211 POLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 212 POLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 213 POLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 214 POLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 215 POLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 216 POLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 217 POLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 218 POLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 219 POLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 220 POLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 221 POLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 222 POLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 223 POLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 224 POLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 225 POLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 226 POLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 227 POLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 228 SWEDEN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 229 SWEDEN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 230 SWEDEN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 231 SWEDEN MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 232 SWEDEN MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 233 SWEDEN MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 234 SWEDEN I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 235 SWEDEN I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 236 SWEDEN I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 237 SWEDEN TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 238 SWEDEN TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 239 SWEDEN TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 240 SWEDEN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 241 SWEDEN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 242 SWEDEN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 243 SWEDEN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 244 SWEDEN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 245 NORWAY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 246 NORWAY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 247 NORWAY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 248 NORWAY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 249 NORWAY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 250 NORWAY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 251 NORWAY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 252 NORWAY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 253 NORWAY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 254 NORWAY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 255 NORWAY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 256 NORWAY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 257 NORWAY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 258 NORWAY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 259 NORWAY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 260 NORWAY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 261 NORWAY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 262 FINLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 263 FINLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 264 FINLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 265 FINLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 266 FINLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 267 FINLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 268 FINLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 269 FINLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 270 FINLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 271 FINLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 272 FINLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 273 FINLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 274 FINLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 275 FINLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 276 FINLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 277 FINLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 278 FINLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 279 REST OF EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
그림 목록
FIGURE 1 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SEGMENTATION
FIGURE 2 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: DROC ANALYSIS
FIGURE 4 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: EUROPE VS COUNTRY MARKET ANALYSIS
FIGURE 5 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: MARKET END USER GRID
FIGURE 9 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SEGMENTATION
FIGURE 11 INCREASING GERIATRIC POPULATIONAND RISING PREVALENCE OF GLAUCOMA IS EXPECTED TO DRIVE THE EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 12 PRODUCT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET IN 2023 TO 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET
FIGURE 14 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT TYPE, 2022
FIGURE 15 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION)
FIGURE 16 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 17 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 18 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, 2022
FIGURE 19 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, 2023- 2030 (USD MILLION)
FIGURE 20 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, CAGR (2023- 2030)
FIGURE 21 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, LIFELINE CURVE
FIGURE 22 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, 2022
FIGURE 23 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, 2023-2030 (USD MILLION)
FIGURE 24 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, CAGR (2023-2030)
FIGURE 25 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, LIFELINE CURVE
FIGURE 26 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY GLAUCOMA TYPE, 2022
FIGURE 27 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY GLAUCOMA TYPE, 2023-2030 (USD MILLION)
FIGURE 28 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY GLAUCOMA TYPE, CAGR (2023-2030)
FIGURE 29 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY GLAUCOMA TYPE, LIFELINE CURVE
FIGURE 30 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, 2022
FIGURE 31 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 32 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, CAGR (2023- 2030)
FIGURE 33 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, LIFELINE CURVE
FIGURE 34 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 35 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 36 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 37 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 38 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SNAPSHOT (2022)
FIGURE 39 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY SHARE 2022 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
